Cargando…
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238657/ https://www.ncbi.nlm.nih.gov/pubmed/34242572 http://dx.doi.org/10.1016/j.ccell.2021.06.014 |
| _version_ | 1783714946182283264 |
|---|---|
| author | Van Oekelen, Oliver Gleason, Charles R. Agte, Sarita Srivastava, Komal Beach, Katherine F. Aleman, Adolfo Kappes, Katerina Mouhieddine, Tarek H. Wang, Bo Chari, Ajai Cordon-Cardo, Carlos Krammer, Florian Jagannath, Sundar Simon, Viviana Wajnberg, Ania Parekh, Samir |
| author_facet | Van Oekelen, Oliver Gleason, Charles R. Agte, Sarita Srivastava, Komal Beach, Katherine F. Aleman, Adolfo Kappes, Katerina Mouhieddine, Tarek H. Wang, Bo Chari, Ajai Cordon-Cardo, Carlos Krammer, Florian Jagannath, Sundar Simon, Viviana Wajnberg, Ania Parekh, Samir |
| author_sort | Van Oekelen, Oliver |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8238657 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82386572021-06-29 Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma Van Oekelen, Oliver Gleason, Charles R. Agte, Sarita Srivastava, Komal Beach, Katherine F. Aleman, Adolfo Kappes, Katerina Mouhieddine, Tarek H. Wang, Bo Chari, Ajai Cordon-Cardo, Carlos Krammer, Florian Jagannath, Sundar Simon, Viviana Wajnberg, Ania Parekh, Samir Cancer Cell Letter Elsevier Inc. 2021-08-09 2021-06-29 /pmc/articles/PMC8238657/ /pubmed/34242572 http://dx.doi.org/10.1016/j.ccell.2021.06.014 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Van Oekelen, Oliver Gleason, Charles R. Agte, Sarita Srivastava, Komal Beach, Katherine F. Aleman, Adolfo Kappes, Katerina Mouhieddine, Tarek H. Wang, Bo Chari, Ajai Cordon-Cardo, Carlos Krammer, Florian Jagannath, Sundar Simon, Viviana Wajnberg, Ania Parekh, Samir Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma |
| title | Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma |
| title_full | Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma |
| title_fullStr | Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma |
| title_full_unstemmed | Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma |
| title_short | Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma |
| title_sort | highly variable sars-cov-2 spike antibody responses to two doses of covid-19 rna vaccination in patients with multiple myeloma |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238657/ https://www.ncbi.nlm.nih.gov/pubmed/34242572 http://dx.doi.org/10.1016/j.ccell.2021.06.014 |
| work_keys_str_mv | AT vanoekelenoliver highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT gleasoncharlesr highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT agtesarita highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT srivastavakomal highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT beachkatherinef highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT alemanadolfo highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT kappeskaterina highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT mouhieddinetarekh highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT wangbo highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT chariajai highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT cordoncardocarlos highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT krammerflorian highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT jagannathsundar highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT simonviviana highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT wajnbergania highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT parekhsamir highlyvariablesarscov2spikeantibodyresponsestotwodosesofcovid19rnavaccinationinpatientswithmultiplemyeloma |